JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120024

7-Chlorokynurenic acid, NMDA receptor glycine site antagonist

Be the first to review this product! Submit a review

|

(1 Publication)

MW 223.61 Da, Purity >99%. Potent NMDA receptor glycine site antagonist. Water-soluble form available - please see 7-Chlorokynurenic acid sodium salt (ab120255).

View Alternative Names

15-PGDH, 15-hydroxyprostaglandin dehydrogenase [NAD+], AMPA 1, AMPA 2, AMPA 3, AMPA 4, AMPA-selective glutamate receptor 1, AMPA-selective glutamate receptor 2, AMPA-selective glutamate receptor 3, AMPA-selective glutamate receptor 4, AW490526, EIEE27, EPND, FESD, GLUH1, GLUK3, GLUR4C, GRIA1_HUMAN, GRIA2_HUMAN, GRIA3_HUMAN, GRIA4_HUMAN, GRIN 2A, GRIN 2B, GRIN3A, GRIN3B, GluA 4, GluA1, GluA2, GluA3, GluN1, GluN2A, GluN2C, GluR-1, GluR-2, GluR-3, GluR-4, GluR-A, GluR-B, GluR-C, GluR-D, GluR-K1, GluR-K2, GluR-K3, Glutamate Receptor Ionotropic N Methyl D Aspartate 2B, Glutamate Receptor Ionotropic N Methyl D Aspartate 2C, Glutamate Receptor Ionotropic N Methyl D Aspartate subunit 2B, Glutamate Receptor Ionotropic N methyl D aspartate 3A, Glutamate [NMDA] receptor subunit epsilon-1, Glutamate [NMDA] receptor subunit epsilon-2, Glutamate [NMDA] receptor subunit epsilon-3, Glutamate [NMDA] receptor subunit zeta-1, Glutamate ionotropic receptor AMPA type subunit 3, Glutamate receptor, Glutamate receptor 1, Glutamate receptor 2, Glutamate receptor 3, Glutamate receptor 4, Glutamate receptor C, Glutamate receptor ionotrophic AMPA 3, Glutamate receptor ionotrophic AMPA 4, Glutamate receptor ionotropic, Glutamate receptor ionotropic AMPA 1, Glutamate receptor ionotropic AMPA 2, Glutamate receptor ionotropic N methyl D aspartate 1, Glutamate receptor ionotropic N methyl D aspartate 2A, Glutamate receptor ionotropic N methyl D aspartate 3B, Glutamate receptor ionotropic NMDA2B, Glutamate receptor ionotropic, N-methyl-D aspartate, subunit 1, Glutamate receptor ionotropic, NMDA 2C, Glutamate receptor subunit 3, Glutamate receptor subunit epsilon 2, Glutamate receptor, ionotropic, AMPA 3, Glutamate receptor, ionotropic, NMDA2B (epsilon 2), Grin2c, HBGR1, HBGR2, Hpgd, Hydroxyprostaglandin dehydrogenase 15 (NAD), Ionotrophic Glutamate Receptor, Ionotropic Glutamate receptor 4, LKS, MGC133252, MGC142178, MGC142180, MRD6, MRD8, MRX94, N Methly D Aspartate Receptor Channel Subunit Epsilon 3, N methyl D asparate receptor channel subunit epsilon 2, N methyl D aspartate receptor channel subunit zeta 1, N methyl D aspartate receptor channel, subunit epsilon 1, N methyl D aspartate receptor subunit 2A, N methyl D aspartate receptor subunit 2B, N methyl D aspartate receptor subunit 2C, N-methyl D-aspartate receptor subtype 2A, N-methyl D-aspartate receptor subtype 2B, N-methyl D-aspartate receptor subtype 2C, N-methyl-D-aspartate receptor, N-methyl-D-aspartate receptor subunit 3, N-methyl-D-aspartate receptor subunit NR1, NAD+ dependent 15 hydroxyprostaglandin dehydrogenase, NMD-R1, NMDA 1, NMDA NR2B, NMDA receptor 1, NMDA receptor subtype 2A, NMDA receptor subunit 3A, NMDA receptor subunit 3B, NMDAR, NMDAR2C, NMDE1_HUMAN, NMDE2_HUMAN, NMDE3_HUMAN, NMDZ1_HUMAN, NR1, NR2A, NR2B, NR2C, NR3, OTTHUMP00000041930, OTTHUMP00000160135, OTTHUMP00000160643, OTTHUMP00000165781, OTTHUMP00000174531, OTTHUMP00000218960, OTTHUMP00000219016, OTTHUMP00000219018, OTTHUMP00000224241, OTTHUMP00000224242, OTTHUMP00000224243, PGDH1, PGDH_HUMAN, PHOAR1, Prostaglandin dehydrogenase 1, SDR36C1, Short chain dehydrogenase/reductase family 36C member 1, dJ1171F9.1, glutamate receptor ionotropic, NMDA 1, hNR 3, hNR2A

2 Images
Functional Studies - 7-Chlorokynurenic acid, NMDA receptor glycine site antagonist (AB120024)
  • FuncS

Unknown

Functional Studies - 7-Chlorokynurenic acid, NMDA receptor glycine site antagonist (AB120024)

ab12416 staining cGMP in SKNSH cells treated with 7-Chlorokynurenic acid (ab120024), by ICC/IF. Decrease in cGMP expression correlates with increased concentration of 7-Chlorokynurenic acid, as described in literature.
The cells were incubated at 37°C for 15 minutes in media containing different concentrations of ab120024 (7-Chlorokynurenic acid) in DMSO. Some samples where then further incubated with 15 µM NMDA (ab120052) for 5 minutes and all samples were fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab12416 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Chemical Structure - 7-Chlorokynurenic acid, NMDA receptor glycine site antagonist (AB120024)
  • Chemical Structure

Lab

Chemical Structure - 7-Chlorokynurenic acid, NMDA receptor glycine site antagonist (AB120024)

2D chemical structure image of ab120024, 7-Chlorokynurenic acid, NMDA receptor glycine site antagonist

Key facts

CAS number

18000-24-3

Purity

>99%

Form

Solid

form

Molecular weight

223.61 Da

Molecular formula

C<sub>1</sub><sub>0</sub>H<sub>6</sub>ClNO<sub>3</sub>

PubChem

1884

Nature

Synthetic

Solubility

Soluble in 1 eq. NaOH to 100 mM

Soluble in DMSO to 100 mM

Biochemical name

7-Chlorokynurenic acid

Biological description

Potent NMDA receptor glycine site antagonist. Water-soluble form available - please see 7-Chlorokynurenic acid sodium salt (ab120255).

Canonical smiles

C1=CC2=C(C=C1Cl)NC(=CC2=O)C(=O)O

InChi

InChI=1S/C10H6ClNO3/c11-5-1-2-6-7(3-5)12-8(10(14)15)4-9(6)13/h1-4H,(H,12,13)(H,14,15)

InChiKey

UAWVRVFHMOSAPU-UHFFFAOYSA-N

IUPAC Name

7-chloro-4-oxo-1H-quinoline-2-carboxylic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

N-methyl-D-aspartate receptor subunits including NMDAR2A NMDAR2B GluN2C and NMDAR1 play a central role in synaptic signaling in the central nervous system. These subunits combine to form heterotetrameric NMDA receptors also known as NMDARs. The NMDA receptor complex allows for the passage of calcium ions across the neuronal membrane in response to glutamate binding. This process is important for synaptic plasticity and memory function. Glutamate receptors often express in neuronal tissue with alternate subtypes such as AMPA receptors including Glutamate Receptor 1 and Glutamate receptor 3/GluA3 also participating in synaptic transmission. Within the scope of this topic important subunits encompass GluA4 GluN2C NMDAR3A and 3B all with roles in neurotransmission.
Biological function summary

These receptors integrate into complexes that facilitate excitatory postsynaptic potentials. They modulate neuron excitability and contribute to long-term potentiation—a cellular mechanism underlying learning and memory. NMDA receptors along with AMPA subtypes assemble at synaptic junctions allowing them to respond rapidly to neurotransmitter release. Their assembly and location permit precise control over neuronal communication. Across different tissues 15-Prostaglandin Dehydrogenase (15-PGDH) although not part of the glutamate receptor family may influence signals through its enzymatic activity affecting inflammatory processes.

Pathways

Glutamate receptors participate actively in the excitatory neurotransmission pathway and neuroplasticity-related signaling cascades. Their functionality connects closely to the calcium/calmodulin-dependent protein kinase (CaMK) pathway which amplifies synaptic transmission. These receptors also interact functionally with proteins like PSD-95 a postsynaptic density protein that organizes signaling molecules at synapses. Such protein-protein associations ensure that neuronal responses remain finely tuned enabling precise memory and learning processes.

Abnormal functioning of NMDA and related glutamate receptors associates with neurological conditions such as Alzheimer's disease and epilepsy. Excessive receptor activity may lead to excitotoxicity damaging neurons and exacerbating such disorders. Pathological changes often relate to proteins like tau and amyloid-beta in Alzheimer's where glutamate receptor dysregulation contributes to synaptic loss. In epilepsy altered NMDA receptor activity influences convulsive thresholds and seizure occurrences. Understanding these interactions opens pathways for potential therapeutic interventions targeting receptor modulation.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Science advances 8:eabn3264 PubMed35275721

2022

d-Serine controls epidermal vesicle release via NMDA receptor, allowing tissue migration during the metamorphosis of the chordate .

Applications

Unspecified application

Species

Unspecified reactive species

Gabriel Krasovec,Akiko Hozumi,Tomoyuki Yoshida,Takayuki Obita,Mayuko Hamada,Akira Shiraishi,Honoo Satake,Takeo Horie,Hisashi Mori,Yasunori Sasakura
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com